Enhabit Price to Free Cash Flow Ratio 2020-2025 | EHAB
Historical price to free cash flow ratio values for Enhabit (EHAB) since 2020.
| Enhabit Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-12-05 | 9.33 | 8.26 | |
| 2025-09-30 | 8.01 | $1.13 | 7.09 |
| 2025-06-30 | 9.64 | $0.97 | 9.95 |
| 2025-03-31 | 8.79 | $0.98 | 8.94 |
| 2024-12-31 | 7.81 | $0.94 | 8.27 |
| 2024-09-30 | 7.90 | $1.10 | 7.20 |
| 2024-06-30 | 8.92 | $0.63 | 14.07 |
| 2024-03-31 | 11.65 | $0.63 | 18.54 |
| 2023-12-31 | 10.35 | $0.90 | 11.50 |
| 2023-09-30 | 11.25 | $0.89 | 12.70 |
| 2023-06-30 | 11.50 | $0.80 | 14.37 |
| 2023-03-31 | 13.91 | $2.05 | 6.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.472B | $1.035B |
| Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $159.812B | 29.35 |
| HCA Healthcare (HCA) | United States | $111.062B | 18.39 |
| CVS Health (CVS) | United States | $96.007B | 11.04 |
| Elevance Health (ELV) | United States | $73.506B | 10.78 |
| Cencora (COR) | United States | $65.892B | 21.24 |
| Natera (NTRA) | United States | $33.751B | 0.00 |
| DiDi Global (DIDIY) | China | $24.867B | 20.32 |
| Labcorp Holdings (LH) | United States | $21.421B | 16.33 |
| Medpace Holdings (MEDP) | United States | $15.439B | 38.33 |
| ICON (ICLR) | Ireland | $15.010B | 14.89 |
| BioMerieux (BMXMF) | France | $14.822B | 0.00 |
| Solventum (SOLV) | United States | $14.818B | 14.38 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.851B | 0.00 |
| Viatris (VTRS) | United States | $12.589B | 4.69 |
| CochLear (CHEOY) | Australia | $11.653B | 0.00 |
| Revvity (RVTY) | United States | $11.427B | 21.04 |
| Charles River Laboratories (CRL) | United States | $9.071B | 17.47 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.143B | 0.00 |
| HealthEquity (HQY) | United States | $8.075B | 30.19 |
| Sonic Healthcare (SKHHY) | Australia | $7.567B | 0.00 |
| Avantor (AVTR) | United States | $7.452B | 11.39 |
| BrightSpring Health Services (BTSG) | United States | $6.455B | 38.48 |
| Bausch + Lomb (BLCO) | Canada | $5.958B | 39.12 |
| PACS (PACS) | United States | $4.817B | 29.30 |
| Sotera Health (SHC) | United States | $4.759B | 22.95 |
| GeneDx Holdings (WGS) | United States | $4.595B | 80.69 |
| Alignment Healthcare (ALHC) | United States | $3.912B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.508B | 20.47 |
| Concentras Parent (CON) | United States | $2.495B | 15.58 |
| Surgery Partners (SGRY) | United States | $2.223B | 28.65 |
| Progyny (PGNY) | United States | $2.071B | 40.71 |
| Establishment Labs Holdings (ESTA) | United States | $2.055B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.900B | 11.34 |
| Organon (OGN) | United States | $1.856B | 1.96 |
| Teladoc Health (TDOC) | United States | $1.347B | 0.00 |
| Ardent Health (ARDT) | United States | $1.259B | 4.11 |
| Nutex Health (NUTX) | United States | $1.138B | 8.70 |
| Omada Health (OMDA) | $1.013B | 0.00 | |
| CareDx (CDNA) | United States | $0.953B | 15.57 |
| GoodRx Holdings (GDRX) | United States | $0.920B | 15.06 |
| Embecta (EMBC) | United States | $0.684B | 3.94 |
| InnovAge Holding (INNV) | United States | $0.682B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.625B | 8.60 |
| Sonida Senior Living (SNDA) | United States | $0.578B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.559B | 0.00 |
| Pomdoctor - (POM) | China | $0.552B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.478B | 0.00 |
| SBC Medicals (SBC) | United States | $0.385B | 7.08 |
| Strata Critical Medical (SRTA) | United States | $0.376B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.368B | 5.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.323B | 67.42 |
| So-Young (SY) | China | $0.315B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.313B | 0.00 |
| Oncology Institute (TOI) | United States | $0.298B | 0.00 |
| Agilon Health (AGL) | United States | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| LifeMD (LFMD) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.127B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.119B | 0.00 |
| DocGo (DCGO) | United States | $0.103B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.33 |
| Basel Medical Group (BMGL) | Singapore | $0.020B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |